ARAY (STOCKS)
Accuray Incorporated
$0.510000
-0.044900 (-8.09%)
Prev close: $0.554900
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Stephen R. la Neve
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $57.77M
- Employees
- 990
- P/E (TTM)
- -1.72
- P/B (TTM)
- 1.02
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
3
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q2)
|
$-0.11 | $-0.11 | +0.0022 | +1.96% |
|
Sep 2025 (Q1)
|
$-0.14 | $-0.06 | -0.0788 | -128.76% |
|
Jun 2025 (Q4)
|
$0.00 | $0.02 | -0.0169 | -94.41% |
|
Mar 2025 (Q3)
|
$-0.01 | $-0.05 | +0.0410 | +80.39% |
Financial Statements
| Revenues | $450.90M |
| Benefits Costs and Expenses | $467.65M |
| Cost Of Revenue | $311.86M |
| Costs And Expenses | $467.65M |
| Gross Profit | $139.05M |
| Operating Expenses | $140.37M |
| Research and Development | $47.20M |
| Other Operating Expenses | $93.18M |
| Operating Income/Loss | -$1.33M |
| Income/Loss Before Equity Method Investments | -$21.97M |
| Income/Loss From Continuing Operations After Tax | -$19.32M |
| Income/Loss From Continuing Operations Before Tax | -$16.74M |
| Income/Loss From Equity Method Investments | $5.23M |
| Income Tax Expense/Benefit | $2.57M |
| Income Tax Expense/Benefit, Deferred | $225.00K |
| Interest Expense, Operating | $18.05M |
| Net Income/Loss | -$19.32M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$19.32M |
| Net Income/Loss Available To Common Stockholders, Basic | -$19.32M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.15 |
| Diluted Earnings Per Share | -$0.16 |
| Basic Average Shares | 324,482,000 |
| Diluted Average Shares | 326,823,000 |
| Assets | $456.82M |
| Current Assets | $303.60M |
| Accounts Receivable | $54.38M |
| Inventory | $155.50M |
| Other Current Assets | $93.72M |
| Noncurrent Assets | $153.21M |
| Fixed Assets | $29.01M |
| Other Non-current Assets | $124.20M |
| Liabilities | $394.95M |
| Current Liabilities | $194.61M |
| Accounts Payable | $42.40M |
| Wages | $13.91M |
| Other Current Liabilities | $138.31M |
| Noncurrent Liabilities | $200.34M |
| Long-term Debt | $140.17M |
| Other Non-current Liabilities | $60.17M |
| Equity | $61.87M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $61.87M |
| Liabilities And Equity | $456.82M |
| Net Cash Flow From Operating Activities | $22.33M |
| Net Cash Flow From Operating Activities, Continuing | $22.33M |
| Net Cash Flow From Investing Activities | -$11.23M |
| Net Cash Flow From Investing Activities, Continuing | -$11.23M |
| Net Cash Flow From Financing Activities | -$2.55M |
| Net Cash Flow From Financing Activities, Continuing | -$2.55M |
| Exchange Gains/Losses | $243.00K |
| Net Cash Flow | $8.80M |
| Net Cash Flow, Continuing | $8.55M |
| Comprehensive Income/Loss | -$15.89M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$18.81M |
| Other Comprehensive Income/Loss | $2.13M |